462 related articles for article (PubMed ID: 16451338)
1. Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania.
Kibona SN; Matemba L; Kaboya JS; Lubega GW
Trop Med Int Health; 2006 Feb; 11(2):144-55. PubMed ID: 16451338
[TBL] [Abstract][Full Text] [Related]
2. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985].
Pérez Martín O; Lastre González M; Urban M; Shwalbach J
Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of multiple drug resistance in Trypanosoma brucei rhodesiense isolated from sleeping sickness patients.
Kagira JM; Maina N
Onderstepoort J Vet Res; 2007 Mar; 74(1):17-22. PubMed ID: 17708149
[TBL] [Abstract][Full Text] [Related]
4. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
Maina N; Maina KJ; Mäser P; Brun R
Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Ugandan Trypanosoma brucei rhodesiense isolated from man and animal reservoirs to diminazene, isometamidium and melarsoprol.
Matovu E; Iten M; Enyaru JC; Schmid C; Lubega GW; Brun R; Kaminsky R
Trop Med Int Health; 1997 Jan; 2(1):13-8. PubMed ID: 9018298
[TBL] [Abstract][Full Text] [Related]
6. Berenil (diminazene aceturate)-resistant Trypanosoma congolense in cattle under natural tsetse challenge at Kibaha, Tanzania.
Mbwambo HA; Mella PN; Lekaki KA
Acta Trop; 1988 Sep; 45(3):239-44. PubMed ID: 2903625
[TBL] [Abstract][Full Text] [Related]
7. Differential virulence of Trypanosoma brucei rhodesiense isolates does not influence the outcome of treatment with anti-trypanosomal drugs in the mouse model.
Ndung'u K; Murilla GA; Thuita JK; Ngae GN; Auma JE; Gitonga PK; Thungu DK; Kurgat RK; Chemuliti JK; Mdachi RE
PLoS One; 2020; 15(11):e0229060. PubMed ID: 33151938
[TBL] [Abstract][Full Text] [Related]
8. Response of a T. b. rhodesiense stock with reduced drug susceptibility in vitro to treatment in mice and cattle.
Enyaru JC; Matovu E; Lubega GW; Kaminsky R
Acta Trop; 1998 Jun; 69(3):261-9. PubMed ID: 9638278
[TBL] [Abstract][Full Text] [Related]
9. Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance.
Bernhard SC; Nerima B; Mäser P; Brun R
Int J Parasitol; 2007 Nov; 37(13):1443-8. PubMed ID: 17602691
[TBL] [Abstract][Full Text] [Related]
10. A diminazene-resistant strain of Trypanosoma brucei brucei isolated from a dog is cross-resistant to pentamidine in experimentally infected albino rats.
Anene BM; Ezeokonkwo RC; Mmesirionye TI; Tettey JN; Brock JM; Barrett MP; De Koning HP
Parasitology; 2006 Jan; 132(Pt 1):127-33. PubMed ID: 16393361
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium.
Zhang ZQ; Giroud C; Baltz T
Acta Trop; 1991 Dec; 50(2):101-10. PubMed ID: 1685865
[TBL] [Abstract][Full Text] [Related]
12. Influence of trypanocidal therapy on the haematology of vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense.
Ngotho M; Kagira JM; Kariuki C; Maina N; Thuita JK; Mwangangi DM; Farah IO; Hau J
Acta Trop; 2011 Jul; 119(1):14-8. PubMed ID: 21420376
[TBL] [Abstract][Full Text] [Related]
13. [Three patients with African sleeping sickness following a visit to Tanzania].
Mendonça Melo M; Rasica M; van Thiel PP; Richter C; Kager PA; Wismans PJ
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2552-6. PubMed ID: 12532670
[TBL] [Abstract][Full Text] [Related]
14. Effect of in vitro cultivation on the stability of resistance of Trypanosoma brucei brucei to diminazene, isometamidium, quinapyramine, and Mel B.
Kaminsky R; Zweygarth E
J Parasitol; 1989 Feb; 75(1):42-5. PubMed ID: 2918443
[TBL] [Abstract][Full Text] [Related]
15. Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO).
Iten M; Matovu E; Brun R; Kaminsky R
Trop Med Parasitol; 1995 Sep; 46(3):190-4. PubMed ID: 8533023
[TBL] [Abstract][Full Text] [Related]
16. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Gehrig S; Efferth T
Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
[TBL] [Abstract][Full Text] [Related]
17. The phenomenon of treatment failures in Human African Trypanosomiasis.
Brun R; Schumacher R; Schmid C; Kunz C; Burri C
Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
[TBL] [Abstract][Full Text] [Related]
18. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
Nok AJ
Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
[TBL] [Abstract][Full Text] [Related]
19. Five-fold increase in Trypanosoma congolense isolates resistant to diminazene aceturate over a seven-year period in Eastern Zambia.
Delespaux V; Dinka H; Masumu J; Van den Bossche P; Geerts S
Drug Resist Updat; 2008 Dec; 11(6):205-9. PubMed ID: 18993109
[TBL] [Abstract][Full Text] [Related]
20. Trypanosoma evansi: in vivo and in vitro determination of trypanocide resistance profiles.
Zhang ZQ; Giroud C; Baltz T
Exp Parasitol; 1993 Dec; 77(4):387-94. PubMed ID: 8253152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
